Paroxysmal Hemicrania-Trigeminal Neuralgia (PH-Tic) syndrome with no structural lesion in a Brazilian woman: the first case-report / Síndrome de Neuralgia Paroxística Hemicrânia-Trigêmea (PH-Tic) sem lesão estrutural em mulher brasileira: primeiro relato de caso

Introduction: In Brazil there is only one case report of a patient diagnosed with Paroxysmal Hemicrania-Trigeminal (PH-Tic) syndrome reported, however it was observed in a patient with Chiari I malformation. Objective: Here, we describe the first case of primary PH-Tic syndrome in the country. Method: Case report. CARE guideline was used to guide the structuring of this article. This case report was approved by the ethics committee and has been registered under the protocol number 70705623.7.0000.5440 on "Plataforma Brasil". Results:A 72-year-old woman with a five-month history of headaches was admitted at our headache outpatient clinic. The pain was sharp, intense, localized in the periorbital and left temporal regions. Blood counts, liver, renal and thyroid function were normal, as well as brain magnetic resonance imaging. Despite using carbamazepine, the patient had pain in only the left side of the face. Indomethacin was added until the dose of 100 mg a day and resulted in improvement of headache frequency. Conclusion: PH-Tic should be hypothesized in patients with short-lasting headaches associated with facial pain that partially improve with carbamazepine or indomethacin.

Introdução: No Brasil há apenas um relato de caso de paciente com diagnóstico de síndrome Paroxística Hemicrania-Trigeminal (PH-Tic), porém foi observado em um paciente com malformação de Chiari I. Objetivo: Descrevemos aqui o primeiro caso de síndrome PH-Tic primária no país. Método: Relato de caso. A diretriz CARE foi utilizada para orientar a estruturação deste artigo. Este relato de caso foi aprovado pelo comitê de ética e registrado sob o número de protocolo 70705623.7.0000.5440 na "Plataforma Brasil". Resultados: Uma mulher de 72 anos com história de cefaleias há cinco meses foi internada em nosso ambulatório de cefaleias. A dor era aguda, intensa, localizada nas regiões periorbital e temporal esquerda. Os hemogramas, as funções hepática, renal e tireoidiana estavam normais, assim como a ressonância magnética cerebral. Apesar do uso de carbamazepina, o paciente apresentava dor apenas no lado esquerdo da face. A indometacina foi adicionada até a dose de 100 mg ao dia e resultou em melhora da frequência da cefaleia. Conclusão: O PH-Tic deve ser hipotetizado em pacientes com cefaleias de curta duração associadas a dores faciais que melhoram parcialmente com carbamazepina ou indometacina.

Dealing with cancer screening in the COVID-19 era

SUMMARY OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19.

Agenesia pulmonar em gêmeos monozigóticos: relato de caso / Pulmonary agenesis in monozygotic twins: case report

Agenesia pulmonar é uma anormalidade congênita extremamente rara com prevalência estimada de 24-34 casos por 1.000,000 nascidos vivos e estar frequentemente associada com outras malformações congênitas. Descrevemos um caso de agenesia pulmonar em gêmeos monozigóticos, no qual a ausência dos pulmões teve apresentação em espelho- o primeiro gemelar com agenesia de pulmão esquerdo e o segundo gemelar com agenesia de pulmão direito. Houve associação com fenda palatina e lábio leporino no primeiro gêmeo e no segundo gêmeo houve associação com polidactilia. Este diagnóstico foi feito ao nascimento. O diagnóstico de agenesia pulmonar e outras malformações congênitas podem ser realizados durante exame pré-natal por ultra-sonografia morfológica. É importante uma identificação precoce da malformação pulmonar para melhor assistência ao recém-nascido. (AU)

Pulmonary agenesis is a congenital anomaly extremely rare with estimated prevalence of 24-34 cases for each 1,000,000 live births and it is frequently associated with other congenital malformations. We describe a case of pulmonary agenesis in monozygotic twins, in which the absence of the lungs has a mirror presentation - the first twin with left lung agenesis and the second twin with right lung agenesis. There was association with cleft palate and cleft lip in the first twin and, in the second twin, there was association with polydactyly. This diagnosis was made to birth.The diagnosis of pulmonary agenesis and other congenital malformations can be made during prenatal exams by morphological ultrasonoghapy. Early identification of the pulmonary malformation is important for better care of the newborn. (AU)